Bailard, Inc.

SEC CIK: 0000750641
Latest filing: Jul 30, 2026

SEC filings (opens in a new tab)

ZNTL holding history

Zentalis Pharmaceuticals, Inc. in every 13F filed by Bailard, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ZNTL overview All 13F holders of ZNTL Full Q2 2026 holdings

Shares (Q4 2021): 0; Sold out in Q4 2021
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q2 2021

Holdings of ZNTL by Bailard, Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2021	0	$0	0.0%	−26,000−100.0%	Sold out	Holders
Q3 2021	26,000	$1.73M	0.1%	−5,500−17.5%	Reduced	Holders
Q2 2021	31,500	$1.68M	0.1%	+31,500	New	Holders